Inhibitors of H2-Kd are a class of compounds that function by interfering with the processes that H2-Kd is involved in, rather than directly inhibiting the protein itself. They can be categorized based on their mechanism of action and their target within the cell. H2-Kd inhibitors function by inhibiting calcineurin, a phosphatase that dephosphorylates NFAT and reduces its nuclear translocation, indirectly affecting antigen presentation by H2-Kd. Other inhibitors work by inhibiting mTOR, a master regulator of cell growth and proliferation, which can indirectly affect antigen presentation by H2-Kd.
Several of H2-Kd inhibitors function by inhibiting protein trafficking or disrupting cellular compartments. H2-Kd inhibitors function by inhibiting protein trafficking from the endoplasmic reticulum to the Golgi apparatus, which can affect the presentation of antigens by H2-Kd. Additionally, inhibitors can also disrupt Golgi function and can impede the movement of MHC molecules like H2-Kd to the cell surface. Other inhibitors function by interfering with protein synthesis or degradation. These compounds can affect the production of H2-Kd and its associated antigenic peptides, as well as the processing of antigens for presentation by H2-Kd. In addition, inhibitors function by interfering with DNA replication and transcription, which can affect the expression of H2-Kd.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A is an immunosuppressant that can inhibit calcineurin, a phosphatase that dephosphorylates NFAT, reducing its nuclear translocation and thus, indirectly affecting antigen presentation by H2-Kd. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 is another immunosuppressant that also inhibits calcineurin, thereby potentially interfering with H2-Kd's function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a master regulator of cell growth and proliferation, which can indirectly affect antigen presentation by H2-Kd. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits protein trafficking from the endoplasmic reticulum to the Golgi apparatus, which can affect the presentation of antigens by H2-Kd. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin disrupts Golgi function and can impede the movement of MHC molecules like H2-Kd to the cell surface. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, can interfere with various immune system processes, potentially affecting antigen presentation by H2-Kd. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can prevent the degradation of proteins, potentially affecting the processing of antigens for presentation by H2-Kd. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can change the pH of endosomes and lysosomes, potentially affecting antigen processing and presentation by H2-Kd. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a topoisomerase inhibitor that can interfere with DNA replication and transcription, potentially affecting the expression of H2-Kd. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA synthesis, which can affect the expression of H2-Kd. | ||||||